Heterogeneity in pluripotent stem cell (PSC) aggregation leads to variability in mass transfer and signaling gradients between aggregates, which results in heterogeneous differentiation and therefore variability in product quality and yield. We have characterized a chemical-based method to control aggregate size within a specific, tunable range with low heterogeneity, thereby reducing process variability in PSC expansion. This method enables controlled, scalable, stirred suspension-based manufacturing of PSC cultures that are critical for the translation of regenerative medicine strategies to clinical products.
. (d) Addition of D40 to suspension cultures at seeding only compared to daily addition. (e) Aggregate formation efficiency of PSC seeded at clonal densities in suspension in Nutristem medium (n = 4, p < 0.05, t-test). DS, dextran sulfate; PSC, pluripotent stem cell [Color figure can be viewed at wileyonlinelibrary.com]
In addition to developmental aspects associated with aggregate size control, there are also significant bioprocess manufacturing considerations. Robust bioprocesses are those that produce a consistent output in spite of variability in input parameters. Subtle variability in cell culture conditions leads to batch-to-batch variability in adhesion molecule expression and other influential parameters.
This can lead to inter-and intrabatch heterogeneity in the aggregate formation that poses a significant challenge to process development (Lipsitz, Timmins, & Zandstra, 2016) . In particular, aggregate size control can be used to minimize nutrient gradients within the aggregate, supporting the maintenance of a viable, undifferentiated, and homogeneous PSC population. We previously described a method for mechanically controlling aggregate size at the laboratory scale (Ungrin et al., 2012; Ungrin, Joshi, Nica, Bauwens, & Zandstra, 2008) ; however, no analogous technologies have been developed for scalable aggregate manufacturing. This study aimed to develop a technique to control single-cell human PSC aggregation in stirred suspension.
| RESULTS
A review of biopharmaceutical manufacturing literature led us to identify dextran sulfate (DS)-based chemistries as a potential chemical method for controlling human PSC aggregation properties without loss of pluripotency. DS is a well-characterized polysulfated compound used to prevent aggregation of cells in biopharmaceutical manufacturing (Dee, Shuler, & Wood, 1997; Hyoung Park, Sin Lim, Rang Woo, Won Kim, & Min Lee, 2016; Renner, Jordan, Eppenberger, & Leist, 1993) . To guide stirred tank bioreactor studies, we first varied the concentration of DS in small-scale orbital shaker suspension culture using three-molecularweight DS: 4,000 kDA (D4), 15,000 kDA (D15), and 40,000 kDA (D40).
In each of these conditions, we observed changes in PSC aggregation properties compared with the PSC medium control (Figure 1b ). The addition of DS to the medium resulted in the formation of aggregates with significantly reduced diameters in a dose-dependent fashion ( Figure 1c and Supporting Information Figure S1b ). In addition, more homogeneous aggregate sizes were observed in the presence of DS, as evidenced by reduced standard deviations and lower coefficients of variation of aggregate volume (Supporting Information Figure S1a ).
However, in the absence of DS, large, heterogeneous aggregates formed, with a small number of very large aggregates (diameter 150-700 µm) that contained a large fraction of the cells (Figure 1c and Supporting Information Figures S1b and S1c).
To maintain homogeneous aggregate sizes throughout the culture period, DS treatment is only required during PSC seeding.
Similar aggregate sizes were observed at each time point in both conditions where PSC were treated with D40 either daily or only at cell seeding ( Figure 1d ). In biopharmaceutical applications, it has been suggested that DS acts as an antiapoptotic agent during the exponential growth phase of cell culture (Jing et al., 2011; Zanghi, Renner, Bailey, & Fussenegger, 2000) . To test the antiapoptotic effect of DS, we seeded PSC into static suspension conditions at low densities typically used for clonal expansion. In the presence of 100 μg/ml all DS compounds, we observed enhanced cell survival and aggregate formation over untreated conditions ( Figure 1e ).
We next evaluated the capacity for small, homogeneous DS aggregates to expand in culture over a 6-day culture period. In suspension culture on an orbital shaker, small aggregates formed in D40 remained small and homogeneous throughout the 6-day expansion relative to the large and heterogeneous untreated aggregates ( Figure 2a ). Translating these orbital shaker findings to scalable stirred suspension bioreactors for PSC culture confirmed that D40 at seeding was associated with reduced aggregate size throughout the process relative to untreated PSC (Figure 2b ). After 6 days in stirred suspension, untreated PSC displayed large, heterogeneous aggregate morphologies in both bioreactor geometries. Furthermore, in stirred tank bioreactors seeded with DS, PSC were successfully expanded for three passages while maintaining high expression of pluripotency markers Oct4 and Sox2 (>85%; Supporting Information Figure S1d ). Importantly, after nine passages (five passages in adherent conditions, four passages in suspension), DS-treated PSC retained a normal karyotype (Supporting Information Figure S1e ) and maintained the ability to differentiate into cell types from all three germ layers (Supporting Information Figure S1f ).
These findings indicate that DS treatment enables uniform aggregate formation without causing a loss of pluripotency or introducing karyotypic instability.
We next investigated the fate of large PSC aggregates that arise in control cultures to understand the benefit that DS conveys to PSC suspension expansion. By extending the suspension culture period to 10 days, untreated PSC cultures were observed to contain primarily large, heterogeneous aggregates, whereas D40-treated conditions were observed to contain small, homogeneous aggregates (Supporting Information Figure S1g ). The untreated, large, dark aggregates exhibited elevated expression of early apoptotic marker annexin V (Figure 2c ). When dissociated and reseeded in suspension, D40-treated cells again formed small, homogeneous aggregates, whereas control cells formed large heterogeneous aggregates. The cell recovery following dissociation after 2 days in culture was significantly enhanced in the D40-treated PSC (Figure 2d ). Heterogeneous aggregation in the first passage preceded reduced cell recovery, lower pluripotency marker expression, and, ultimately, lower cell yield after 6 days of a second passage (Figure 2e ). It appears that DS enhances process robustness by mitigating the risk that variable and difficult-to-control input factors cause large aggregate formation. These large aggregates would otherwise lead to reduced cell viability and expansion potential and may impact downstream differentiation capacity. In addition to the HES2 line, DS is broadly applicable for aggregation control across different cell lines and culture conditions. We cultured the H9 PSC line in a medium containing DS in both conventional PSC culture conditions and conditions supporting a "naïve" pluripotent state (Gafni et al., 2013) and found that the DS is able to control H9 PSC aggregation in both pluripotent states (Supporting Information Figure S1h ). Antiapoptotic activity, cell surface charge modulation (Dee et al., 1997) , and heparan sulfate-based syndecan signaling have all been suggested as mechanisms of action for these molecules (Stanley, Liebersbach, Liu, Anhalt, & Sanderson, 1995) , and may play a role in the aggregation control effects that DS has on PSC. In our study, we observed that although 1,000 μg/ml D15 and D40 lead to the largest number of small aggregates, the total cell number is reduced in these conditions (Supporting Information Figure S1i ). This finding suggests that in addition to antiapoptotic effects of DS, tradeoffs should be considered between the increased growth potential of small PSC aggregates, inhibitory maximum DS concentrations, the availability of prosurvival signals received by cells in small aggregates, and additional mechanisms of action.
We have shown that PSC in large aggregates rapidly lose pluripotency, undergo increased apoptosis, and lose the ability to be successfully passaged in suspension. These findings underscore F I G U R E 2 Aggregation control and culture robustness. (a) Representative phase contrast images of PSC aggregates in orbital shaker suspension culture and stirred tank bioreactor culture (b) in the presence and absence of 100 μg/ml D40 at seeding. (c) Expression level of early apoptotic marker annexin V after 10 days in orbital shaker culture (n = 4, p < 0.05, the t-test). (d) Cell recovery measured 2 days after seeding of passage 2 of PSC in suspension, in the presence and absence of 100 μg/ml D40 (n = 4, p < 0.05, t-test). (e) Suspension cell yield in the presence and absence of 100 μg/ml D40 after two passages in suspension (n = 6, p < 0.05, t-test). PSC, pluripotent stem cell [Color figure can be viewed at wileyonlinelibrary.com] mitigate the risk that variability in input parameters will cause unexpected outcomes. Poor repeatability in PSC aggregation is a widespread concern in the field (Hookway, Butts, Lee, Tang, & McDevitt, 2016) . To date, the factors that affect human PSC aggregate formation properties are not well understood; however, with Geltrex for 30 min at 37°C. Cells were passaged 1:24 every 6 days by dissociation with TrypLE Express (Thermo Fisher) at 37°C for 4-5 min. All cell line stocks were confirmed negative for mycoplasma contamination. Conversion to a human "naïve" PSC state was performed as described previously (Gafni et al., 2013) . DS compounds (Sigma-Aldrich, St Louis, MO) were prepared by dilution in deionized water at a stock concentration of 100 mg/ml followed by filter sterilization. bioreactor system (Sartorius, Gottingen, Germany). Cell dissociation and medium exchange were performed as described above.
| Suspension expansion of PSC
Bioreactors were operated at 450 rpm and seeded with 4 × 10 5 cells/ml unless otherwise noted. Aggregates were analyzed using the Mastersizer 3000 particle analyzer (Malvern, Westborough, MA) according to the manufacturer's instructions. Unless otherwise noted, the 560-μm aperture was used for analysis. Aggregates were dissociated and seeded into adherent conditions after three passages in suspension with DS. Directed differentiation into all three germ layers was performed as described previously for endoderm (Ungrin et al., 2012) , mesoderm (Bauwens et al., 2011) , and ectoderm (Fluri et al., 2012) lineages. G-Band karyotyping was performed by WiCell (Madison, WI).
| Flow cytometry and immunocytochemistry
Apoptosis analysis was conducted using Annexin V staining.
Dissociated cells were resuspended in Hank's Buffered Saline Solution (Thermo Fisher) supplemented with 2% fetal bovine serum (HF; Thermo Fisher). Cells were washed once in HF and then resuspended in the Annexin V Binding Buffer (BD Biosciences)
